Arvinas ARVN
NASDAQ ARVN
$9.39 +0.08 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arvinas (ARVN) Change in Cash (2017 - 2026)

Arvinas (ARVN) posted quarterly Change in Cash of -$55.6 million for Q1 2026, down 185.13% year-over-year from $65.3 million in Q1 2025, and down 234.3% quarter-over-quarter from $41.4 million in Q4 2025.

Analysis

Arvinas (ARVN) Change in Cash (2017 - 2026) Analysis & Trends

Arvinas' Change in Cash history runs 10 years deep, the most recent figure standing at -$55.6 million for Q1 2026.

  • In Q1 2026, Change in Cash fell 185.13% year-over-year to -$55.6 million; the TTM figure through Mar 2026 stood at $6.3 million (up 150.4% YoY), while the FY2025 annual figure was $42.4 million, up 119.57% from the prior year.
  • Change in Cash for Q1 2026 stood at -$55.6 million, down from $41.4 million in the prior quarter.
  • The five-year high for Change in Cash was $198.0 million in Q4 2023, with the low at -$223.7 million in Q1 2024.
  • The 5-year median for Change in Cash is $15.3 million (2024), against an average of -$1.5 million.
  • The sharpest annual moves came in 2023 and 2024: Change in Cash soared 485.96% in 2023, then sank 557.46% in 2024.
  • Arvinas' Change in Cash stood at -$51.3 million in 2022, then jumped by 485.96% to $198.0 million in 2023, then tumbled by 92.27% to $15.3 million in 2024, then surged by 170.59% to $41.4 million in 2025, then plunged by 234.3% to -$55.6 million in 2026.
  • Business Quant data shows ARVN's Change in Cash at -$55.6 million in Q1 2026, $41.4 million in Q4 2025, and -$13.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Arvinas 609.77 Mn 41.87 Mn - 7.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.00 Mn
Mar 31, 2026 -55.60 Mn
Dec 31, 2025 41.40 Mn
Sep 30, 2025 -13.40 Mn
Jun 30, 2025 33.90 Mn
Mar 31, 2025 -19.50 Mn
Dec 31, 2024 15.30 Mn
Sep 30, 2024 -75.10 Mn
Jun 30, 2024 66.80 Mn
Mar 31, 2024 -223.70 Mn
Dec 31, 2023 198.00 Mn
Sep 30, 2023 23.10 Mn
Jun 30, 2023 -39.60 Mn
Mar 31, 2023 48.90 Mn
Dec 31, 2022 -51.30 Mn
Sep 30, 2022 40.40 Mn
Jun 30, 2022 30.90 Mn
Mar 31, 2022 -46.00 Mn
Dec 31, 2021 -147.40 Mn
Sep 30, 2021 207.00 Mn